Robert Cohen - Jun 30, 2021 Form 4 Insider Report for Zomedica Corp. (ZOM)

Role
CEO, Director
Signature
/s/ John Hogoboom, attorney-in-fact
Stock symbol
ZOM
Transactions as of
Jun 30, 2021
Transactions value $
-$322,281
Form type
4
Date filed
6/30/2021, 04:50 PM
Previous filing
Jun 1, 2021
Next filing
Dec 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZOM Common Stock, without par value Options Exercise $125K +544K $0.23 544K Jun 30, 2021 Direct
transaction ZOM Common Stock, without par value Sale -$447K -544K -100% $0.82 0 Jun 30, 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZOM Stock option (right to buy) Options Exercise $0 -544K -5.03% $0.00 10.3M Jun 30, 2021 Common Stock, without par value 544K $0.23 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.815 to $0.845 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F3 The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021.